31 related articles for article (PubMed ID: 9037258)
1. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.
Hiss DC; Gabriels GA; Folb PI
Cancer Cell Int; 2007 Apr; 7():5. PubMed ID: 17439664
[TBL] [Abstract][Full Text] [Related]
2. In Memoriam: Cecil Rice, Ph.D., CGP, DFAGPA.
Grundy D; Klein RH
Int J Group Psychother; 2017 Oct; 67(4):629-636. PubMed ID: 38475600
[No Abstract] [Full Text] [Related]
3. Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an
Ji N; Yang Y; Cai CY; Wang JQ; Lei ZN; Wu ZX; Cui Q; Yang DH; Chen ZS; Kong D
Front Oncol; 2019; 9():514. PubMed ID: 31275850
[TBL] [Abstract][Full Text] [Related]
4. Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies.
Módos D; Bulusu KC; Fazekas D; Kubisch J; Brooks J; Marczell I; Szabó PM; Vellai T; Csermely P; Lenti K; Bender A; Korcsmáros T
NPJ Syst Biol Appl; 2017 Jan; 3():2. PubMed ID: 28603644
[TBL] [Abstract][Full Text] [Related]
5. Protein kinases and multidrug resistance.
Rumsby MG; Drew L; Warr JR
Cytotechnology; 1998 Sep; 27(1-3):203-24. PubMed ID: 19002793
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C inhibitors.
Swannie HC; Kaye SB
Curr Oncol Rep; 2002 Jan; 4(1):37-46. PubMed ID: 11734112
[TBL] [Abstract][Full Text] [Related]
7. Analogs of staurosporine: potential anticancer drugs?
Gescher A
Gen Pharmacol; 1998 Nov; 31(5):721-8. PubMed ID: 9809468
[TBL] [Abstract][Full Text] [Related]
8. Staurosporine analogues - pharmacological toys or useful antitumour agents?
Gescher A
Crit Rev Oncol Hematol; 2000 May; 34(2):127-35. PubMed ID: 10799837
[TBL] [Abstract][Full Text] [Related]
9. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
10. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
[TBL] [Abstract][Full Text] [Related]
12. The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251.
Killion JJ; Beltran P; O'Brian CA; Yoon SS; Fan D; Wilson MR; Fidler IJ
Oncol Res; 1995; 7(9):453-9. PubMed ID: 8835289
[TBL] [Abstract][Full Text] [Related]
13. Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells.
Sachs CW; Ballas LM; Mascarella SW; Safa AR; Lewin AH; Loomis C; Carroll FI; Bell RM; Fine RL
Biochem Pharmacol; 1996 Aug; 52(4):603-12. PubMed ID: 8759033
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation.
Beltran PJ; Fan D; Fidler IJ; O'Brian CA
Biochem Pharmacol; 1997 Jan; 53(2):245-7. PubMed ID: 9037258
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
